THE MOSES H. CONE MEMORIAL HOSPITAL LIBRARY
DEE.
APRIL 1992
Friends and Colleagues
1991 Publications - Part II
Brodie BR, Stuckey TD, Cooper TR, Hansen CJ, Weintraub RA, LeBauer EJ, Katz
JD, Kelly TA. The importance of a patent infarct related artery for late
survival after direct angioplasty for acute myocardial infarction (Abstract).
JACC;17(2):215A.
Brodie BR, et al. Effects of direct angioplasty on hospital costs in acute
myocardial infarction: Results from the multicenter PAR study (Abstract).
Circ;84(4):II-256.
Brodie BR, et al. Initial report of the Primary Angioplasty
Revascularization (PAR) Multicenter Registry (Abstract). Circ;84(4):11-536.
Curnes JT, et al. Hamartomas of the Tuber Cinereum: CT, MR, and pathologic
findings. AJNR Am J Neuroradiol;12(2):309-14.
Curnes JT, et al. Neuroimaging of a new familial disorder: Ataxia, Chorea,
Seizures, and Dementia. J Neuroimag;1:123-128.
Johnson AM, et al. An improved method for determining high molecular weights
by protein immunoblotting: Application to apolipoprotein(a) phenotyping.
Appl Theoret Electrophoresis;2:135-140.
Johnson AM, et al. Specifications for Immunological Testing for Infectious
Diseases. National Committee for Clinical Laboratory Standards (NCCLS)
Document I/LA18-P, Philadelphia, 1991.
Johnson AM, et al. Apolipoprotein Immunoassays: Development and Recommended
Performance Characteristics. National Committee for Clinical Laboratory
Standards Document I/LA 15-P, Philadelphia, 1991.
Holmes C, Gal P, Ransom RL, Weaver RL, Wyble LE and Johnson AM.
Heparin concentration in low birth weight infants (Abstract).
Pediat Res;29(4 pt 2):275A.
Johnson AM, et al. An improved method for determining high molecular weights
by immunoblotting: Application to apolipoprotein (a) phenotyping. (Abstract
for poster presentation. International Electrophoresis Society, Washington,
DC, 1991.)
Johnson S, et al. OSHA bloodborne pathogens standard;
Occupational Health Nurse. AAOHN;39(4):182-188.
Implications for the
Powell AC, et al. Lack of plasma interleukin-1 beta or tumor necrosis
factor-alpha elevation during unfavorable hemodialysis conditions. J Am Soc
Nephrol;2(5):1007-13.
THE MOSES H. CONE MEMORIAL HOSPITAL LIBRARY
DEE.
APRIL 1992
Friends and Colleagues
1991 Publications - Part II
Brodie BR, Stuckey TD, Cooper TR, Hansen CJ, Weintraub RA, LeBauer EJ, Katz
JD, Kelly TA. The importance of a patent infarct related artery for late
survival after direct angioplasty for acute myocardial infarction (Abstract).
JACC;17(2):215A.
Brodie BR, et al. Effects of direct angioplasty on hospital costs in acute
myocardial infarction: Results from the multicenter PAR study (Abstract).
Circ;84(4):II-256.
Brodie BR, et al. Initial report of the Primary Angioplasty
Revascularization (PAR) Multicenter Registry (Abstract). Circ;84(4):11-536.
Curnes JT, et al. Hamartomas of the Tuber Cinereum: CT, MR, and pathologic
findings. AJNR Am J Neuroradiol;12(2):309-14.
Curnes JT, et al. Neuroimaging of a new familial disorder: Ataxia, Chorea,
Seizures, and Dementia. J Neuroimag;1:123-128.
Johnson AM, et al. An improved method for determining high molecular weights
by protein immunoblotting: Application to apolipoprotein(a) phenotyping.
Appl Theoret Electrophoresis;2:135-140.
Johnson AM, et al. Specifications for Immunological Testing for Infectious
Diseases. National Committee for Clinical Laboratory Standards (NCCLS)
Document I/LA18-P, Philadelphia, 1991.
Johnson AM, et al. Apolipoprotein Immunoassays: Development and Recommended
Performance Characteristics. National Committee for Clinical Laboratory
Standards Document I/LA 15-P, Philadelphia, 1991.
Holmes C, Gal P, Ransom RL, Weaver RL, Wyble LE and Johnson AM.
Heparin concentration in low birth weight infants (Abstract).
Pediat Res;29(4 pt 2):275A.
Johnson AM, et al. An improved method for determining high molecular weights
by immunoblotting: Application to apolipoprotein (a) phenotyping. (Abstract
for poster presentation. International Electrophoresis Society, Washington,
DC, 1991.)
Johnson S, et al. OSHA bloodborne pathogens standard;
Occupational Health Nurse. AAOHN;39(4):182-188.
Implications for the
Powell AC, et al. Lack of plasma interleukin-1 beta or tumor necrosis
factor-alpha elevation during unfavorable hemodialysis conditions. J Am Soc
Nephrol;2(5):1007-13.
